Structures by: Mague J. T.
Total: 822
1-{[3-(Thiophen-2-yl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}-2,3-dihydro-1<i>H</i>-indole-2,3-dione
C16H12N2O3S
IUCrData (2017) 2, 3 x170315
a=7.3834(2)Å b=11.7331(3)Å c=16.9144(4)Å
α=90° β=101.7310(10)° γ=90°
(4<i>Z</i>)-4-(2-Oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C12H12N2O2
IUCrData (2017) 2, 7 x171057
a=4.5801(9)Å b=10.870(2)Å c=10.971(2)Å
α=101.043(3)° β=98.854(3)° γ=99.868(3)°
3-Acetyl-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-4-one
C11H10N2O2
IUCrData (2017) 2, 7 x170991
a=3.7716(6)Å b=10.3959(15)Å c=12.3280(18)Å
α=78.017(2)° β=83.431(2)° γ=81.266(2)°
3-[2-(5-Oxo-4,4-diphenyl-2-sulfanylideneimidazolidin-1-yl)ethyl]-1,3-oxazolidin-2-one
C20H19N3O3S
IUCrData (2017) 2, 7 x171041
a=9.1211(6)Å b=14.6521(9)Å c=14.2448(9)Å
α=90° β=104.0370(10)° γ=90°
4-{[5-Methyl-2-(propan-2-yl)phenoxy]methyl}-1-(4-nitrobenzyl)-1<i>H</i>-1,2,3-triazole
C20H22N4O3
IUCrData (2017) 2, 4 x170516
a=9.4118(3)Å b=10.8934(4)Å c=18.6996(7)Å
α=101.6290(10)° β=91.7520(10)° γ=90.3510(10)°
1-(Prop-2-en-1-yl)-3-[(prop-2-en-1-yl)oxy]quinoxalin-2(1<i>H</i>)-one
C14H14N2O2
IUCrData (2017) 2, 5 x170656
a=8.4015(6)Å b=9.0041(6)Å c=9.1465(7)Å
α=114.214(3)° β=101.275(4)° γ=90.978(3)°
(<i>E</i>)-<i>N</i>-[(Anthracen-9-yl)methylidene]hydroxylamine
C15H11NO
IUCrData (2017) 2, 5 x170684
a=13.463(3)Å b=3.8694(8)Å c=20.377(4)Å
α=90° β=101.023(3)° γ=90°
5,6-Dimethyl-2-[(5-methyl-1,2-oxazol-3-yl)methyl]-1-(prop-2-en-1-yl)-1<i>H</i>-1,3-benzodiazole
C17H19N3O
IUCrData (2017) 2, 7 x170647
a=19.6067(6)Å b=5.5438(2)Å c=14.0069(5)Å
α=90° β=99.911(2)° γ=90°
5-Methyl-4-(3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-3-one
C20H18N4O
IUCrData (2017) 2, 6 x170853
a=18.2838(13)Å b=7.7956(6)Å c=11.8081(8)Å
α=90° β=100.393(3)° γ=90°
3-Chloro-2-ethyl-6-nitro-2<i>H</i>-indazole
C9H8ClN3O2
IUCrData (2017) 2, 5 x170652
a=11.2363(7)Å b=7.4063(5)Å c=12.1247(8)Å
α=90° β=111.0510(10)° γ=90°
5-Fluoro-1-[(1-{[(1<i>S</i>,2<i>R</i>,6<i>R</i>,8<i>S</i>,9<i>R</i>)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0^2,6^]dodecan-8-yl]methyl}-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-2,3-dihydro-1<i>H</i>-indole-2,3-dione
C23H25FN4O7
IUCrData (2017) 2, 5 x170739
a=11.1688(2)Å b=9.0576(2)Å c=11.9237(2)Å
α=90° β=106.7700(10)° γ=90°
4-[(1<i>H</i>-Imidazol-1-yl)methyl]-1-(4-nitrobenzyl)-1<i>H</i>-1,2,3-triazole
C13H12N6O2
IUCrData (2017) 2, 4 x170515
a=20.3330(4)Å b=14.2764(3)Å c=4.50890(10)Å
α=90° β=90° γ=90°
(4<i>Z</i>)-4-(2-Oxopropylidene)-1,3-bis(prop-2-en-1-yl)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C18H20N2O2
IUCrData (2017) 2, 4 x170493
a=8.6864(6)Å b=8.9925(6)Å c=10.9872(7)Å
α=110.6530(10)° β=95.1110(10)° γ=104.7230(10)°
2-[4,5-Diphenyl-2-(pyridin-4-yl)-1<i>H</i>-imidazol-1-yl]ethanol
C22H19N3O
IUCrData (2017) 2, 1 x170132
a=5.7619(2)Å b=22.1304(6)Å c=13.6271(4)Å
α=90° β=99.1020(10)° γ=90°
(2<i>Z</i>)-2-Benzylidene-4-octadecyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C33H47NOS
IUCrData (2017) 2, 5 x170695
a=33.8411(7)Å b=4.71060(10)Å c=18.0987(4)Å
α=90° β=90.4700(10)° γ=90°
1,4-Dihexyl-1,2,3,4-tetrahydroquinoxaline-2,3-dione
C20H30N2O2
IUCrData (2017) 2, 7 x171019
a=13.357(3)Å b=9.209(2)Å c=16.743(4)Å
α=90° β=113.277(3)° γ=90°
(Pyridin-2-yl)methyl 2-oxo-1-[(pyridin-2-yl)methyl]-1,2-dihydroquinoline-4-carboxylate hemihydrate
C22H17N3O3,0.5(H2O)
IUCrData (2017) 2, 7 x171038
a=4.96340(10)Å b=14.0708(3)Å c=25.7168(6)Å
α=90° β=90.6020(10)° γ=90°
1,4-Di-<i>n</i>-octyl-1,2,3,4-tetrahydroquinoxaline-2,3-dione
C24H38N2O2
IUCrData (2017) 2, 4 x170520
a=26.4070(10)Å b=14.3718(5)Å c=12.9624(5)Å
α=90° β=108.312(2)° γ=90°
2-(1-Hexyl-2-oxo-2,3-dihydro-1<i>H</i>-indol-3-ylidene)propanedinitrile
C17H17N3O
IUCrData (2017) 2, 5 x170706
a=12.0350(5)Å b=24.5052(9)Å c=4.9909(2)Å
α=90° β=90° γ=90°
1-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-1<i>H</i>-1,3-benzodiazole
C17H15N5
IUCrData (2017) 2, 6 x170944
a=5.34830(10)Å b=14.1861(4)Å c=19.1408(5)Å
α=90° β=97.4510(10)° γ=90°
Methyl 2-{[(6<i>S*</i>,7<i>R*</i>,8<i>S*</i>)-7-acetyl-8-(4-chlorophenyl)-4-cyano-6-hydroxy-1,6-dimethyl-5,6,7,8-tetrahydroisoquinolin-3-yl]sulfanyl}acetate
C23H23ClN2O4S
IUCrData (2017) 2, 6 x170868
a=27.4679(6)Å b=9.5818(2)Å c=20.2584(5)Å
α=90° β=117.3980(10)° γ=90°
(2<i>Z</i>)-2-(4-Chlorobenzylidene)-4-[2-(2-oxooxazoliden-3-yl)ethyl]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C20H17ClN2O3S
IUCrData (2017) 2, 5 x170646
a=6.2315(3)Å b=15.5466(8)Å c=18.9162(10)Å
α=90° β=98.8450(10)° γ=90°
1-Chloro-3-(6-nitro-1<i>H</i>-indazol-1-yl)propan-2-ol
C10H10ClN3O3
IUCrData (2017) 2, 5 x170637
a=4.3949(4)Å b=9.9144(8)Å c=13.1376(11)Å
α=98.4810(10)° β=90.7550(10)° γ=97.3770(10)°
1-(6-Nitro-1<i>H</i>-indazol-1-yl)ethanone
C9H7N3O3
IUCrData (2017) 2, 6 x170831
a=3.89190(10)Å b=20.4831(6)Å c=11.2580(4)Å
α=90° β=92.7570(10)° γ=90°
5-Nitro-1-(prop-2-en-1-yl)-1<i>H</i>-indazole
C10H9N3O2
IUCrData (2017) 2, 7 x171091
a=6.9549(5)Å b=11.6778(9)Å c=12.2165(9)Å
α=90° β=90° γ=90°
Ethyl 2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)acetate
C19H18N2O4
IUCrData (2017) 2, 1 x170098
a=8.5041(5)Å b=8.6959(5)Å c=12.5024(8)Å
α=71.0020(10)° β=88.1650(10)° γ=72.5720(10)°
1-(3-Bromo-6-nitro-1<i>H</i>-indazol-1-yl)ethan-1-one
C9H6BrN3O3
IUCrData (2017) 2, 5 x170660
a=13.9863(5)Å b=7.8783(3)Å c=18.5549(7)Å
α=90° β=100.7860(10)° γ=90°
1-[(1-{[(1<i>S</i>,2<i>R</i>,6<i>R</i>,8<i>R</i>,9<i>S</i>)-4,4,11,11-Tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0^2,6^]dodecan-8-yl]methyl}-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-2,3-dihydro-1<i>H</i>-indole-2,3-dione
C23H26N4O7
IUCrData (2017) 2, 5 x170670
a=25.6622(8)Å b=8.7731(3)Å c=10.3928(3)Å
α=90° β=101.8470(10)° γ=90°
Diethyl 3-amino-6-methyl-4-[(<i>E</i>)-2-phenylethenyl]thieno[2,3-<i>b</i>]pyridine-2,5-dicarboxylate
C22H22N2O4S
IUCrData (2016) 1, 2 x160270
a=5.6473(2)Å b=26.7798(9)Å c=13.3219(4)Å
α=90° β=99.743(2)° γ=90°
(4<i>E</i>)-1-Phenyl-4-[(piperidin-1-yl)methylidene]pyrazolidine-3,5-dione
C15H17N3O2
IUCrData (2016) 1, 6 x161028
a=6.3184(2)Å b=15.4673(6)Å c=13.2528(5)Å
α=90° β=98.762(2)° γ=90°
4-(2-Oxopropylidene)-1,3-bis(prop-2-yn-1-yl)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C18H16N2O2
IUCrData (2016) 1, 6 x161013
a=8.6905(2)Å b=9.0249(3)Å c=10.8240(3)Å
α=68.8030(10)° β=78.5200(10)° γ=72.9800(10)°
(5<i>Z</i>)-5-(4-Chlorobenzylidene)-1,3-thiazolidine-2,4-dione
C10H6ClNO2S
IUCrData (2016) 1, 6 x160988
a=3.90980(10)Å b=40.7555(15)Å c=6.0917(2)Å
α=90° β=93.7480(10)° γ=90°
2-Oxo-1,2-dihydroquinoline-4-carboxylic acid monohydrate
C10H7NO3,H2O
IUCrData (2016) 1, 6 x160997
a=20.7884(8)Å b=3.72150(10)Å c=23.8849(9)Å
α=90° β=98.582(2)° γ=90°
7-Bromo-2,3-bis[(prop-2-yn-1-yl)sulfanyl]pyrido[2,3-<i>b</i>]pyrazine
C13H8BrN3S2
IUCrData (2016) 1, 11 x161881
a=4.21590(10)Å b=16.7730(5)Å c=19.4656(5)Å
α=90° β=91.1490(10)° γ=90°
3-Hydroxy-4-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C15H14N2O2
IUCrData (2016) 1, 11 x161879
a=5.519(2)Å b=21.594(8)Å c=9.917(4)Å
α=90° β=90.405(5)° γ=90°
4-Amino-3-[2-(9<i>H</i>-carbazol-9-yl)ethyl]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione dimethyl sulfoxide monosolvate
C16H15N5S,C2H6OS
IUCrData (2016) 1, 11 x161855
a=14.7620(4)Å b=7.3509(2)Å c=17.9987(5)Å
α=90° β=106.9360(10)° γ=90°
1-[({5-[(4-Methylphenoxy)methyl]-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl}sulfanyl)methyl]-1<i>H</i>-benzo[<i>d</i>][1,2,3]triazole
C23H20N6OS
IUCrData (2016) 1, 11 x161867
a=13.4306(13)Å b=7.3467(7)Å c=21.643(2)Å
α=90° β=103.2990(10)° γ=90°
3-[2-(9<i>H</i>-Carbazol-9-yl)ethyl]-4-phenyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione dimethyl sulfoxide monosolvate
C22H18N4S,C2H6OS
IUCrData (2016) 1, 11 x161835
a=5.89480(10)Å b=17.7215(4)Å c=22.0042(5)Å
α=90° β=90° γ=90°
(3<i>S</i>,4<i>S</i>)-1-Benzyl-3-hydroxy-4-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C22H20N2O2
IUCrData (2016) 1, 11 x161849
a=8.9169(2)Å b=17.6360(5)Å c=11.7937(3)Å
α=90° β=109.1990(10)° γ=90°
(2<i>Z</i>)-2-Benzylidene-4-[(1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C25H20N4OS
IUCrData (2016) 1, 11 x161823
a=21.8833(8)Å b=5.7007(2)Å c=16.8054(6)Å
α=90° β=100.2340(10)° γ=90°
<i>N</i>,<i>N</i>,<i>N</i>-Triethylethanaminium 5,11,17,23-tetra-<i>tert</i>-butyl-25-cyanomethoxy-26,28-dihydroxy-27-oxido-2,8,14,20-tetrathiacalix[4]arene
C8H20N,C42H48NO4S4
IUCrData (2016) 1, 1 x160115
a=20.7072(8)Å b=20.4462(8)Å c=12.8292(5)Å
α=90° β=107.2940(10)° γ=90°
(<i>E</i>)-4-Methoxy-3,5-dimethyl-2-[(3-nitrophenyl)ethenyl]pyridine
C16H16N2O3
IUCrData (2016) 1, 12 x161966
a=23.3174(7)Å b=8.2979(2)Å c=7.2260(2)Å
α=90° β=90.8990(10)° γ=90°
2-Methyl-3-(3-methylisoxazol-5-yl)-4-oxo-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-1-ium chloride
C13H12N3O2,Cl
IUCrData (2016) 1, 12 x161978
a=6.2796(12)Å b=9.6912(18)Å c=21.152(4)Å
α=90° β=95.294(3)° γ=90°
Ethyl 2-{6-bromo-2-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl}acetate
C16H14BrN3O2
IUCrData (2016) 1, 12 x161999
a=21.1444(14)Å b=7.6970(5)Å c=21.2671(14)Å
α=90° β=118.0730(10)° γ=90°
In,in-bis(triarylphosphine)
C39H30P2S3
Organic Letters (2013) 15, 9 2179
a=14.810(5)Å b=14.810(5)Å c=21.949(8)Å
α=90.00° β=90.00° γ=120.00°
In,in-bis(triarylphosphine) hydrochloride
C39H31ClP2S3,2(CHCl3),Cl,H2O
Organic Letters (2013) 15, 9 2179
a=13.157(2)Å b=19.846(4)Å c=16.443(3)Å
α=90.00° β=94.875(3)° γ=90.00°
In,in-bis(triarylphosphine) hexaoxide
C39H30O6P2S3,1.5(C2H6OS)
Organic Letters (2013) 15, 9 2179
a=17.7602(7)Å b=10.5542(4)Å c=21.7285(8)Å
α=90° β=90° γ=90°
C23H20OS2
C23H20OS2
Organic letters (2010) 12, 5 928-930
a=9.620(3)Å b=12.162(3)Å c=16.180(4)Å
α=90.00° β=100.708(3)° γ=90.00°
C23H20O5S2
C23H20O5S2
Organic letters (2010) 12, 5 928-930
a=20.0117(15)Å b=10.0091(9)Å c=10.6634(9)Å
α=90.00° β=115.921(2)° γ=90.00°
N,N-di(4-methoxyphenyl)-N-([1,2-a]-[2'-1'-j]dinaphthanthracen-9-yl)amine
C28H23NO2
The journal of physical chemistry. A (2011) 115, 30 8361-8368
a=11.7245(19)Å b=11.2382(18)Å c=32.084(5)Å
α=90.00° β=100.429(2)° γ=90.00°
Compound 3
C27H21NS3
Organic letters (2012) 14, 13 3427-3429
a=15.2379(11)Å b=14.5654(11)Å c=19.8667(14)Å
α=90.00° β=90.00° γ=90.00°
C38H38Br2N18O8,O12.25
C38H38Br2N18O8,O12.25
Organic & biomolecular chemistry (2012) 10, 46 9219-9222
a=16.077(2)Å b=17.390(3)Å c=21.894(3)Å
α=90.00° β=109.049(2)° γ=90.00°
C140H122Br4Ni4O8P8,2(CH2Cl2)
C140H122Br4Ni4O8P8,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14632-14641
a=28.0679(15)Å b=21.8228(12)Å c=25.4931(14)Å
α=90° β=114.0480(10)° γ=90°
C140H124Br4O8P8Pd4
C140H124Br4O8P8Pd4
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14632-14641
a=27.9334(7)Å b=21.8518(4)Å c=26.0254(5)Å
α=90° β=114.2120(10)° γ=90°
C22H20N6O2S4Zn
C22H20N6O2S4Zn
New Journal of Chemistry (2020) 44, 21 8878-8889
a=17.0306(6)Å b=15.5145(6)Å c=10.2986(4)Å
α=90° β=113.411(2)° γ=90°
C22H20N6NiO2S4
C22H20N6NiO2S4
New Journal of Chemistry (2020) 44, 21 8878-8889
a=16.812(2)Å b=15.539(2)Å c=10.2873(14)Å
α=90° β=112.258(2)° γ=90°
C22H20N6O2PdS4
C22H20N6O2PdS4
New Journal of Chemistry (2020) 44, 21 8878-8889
a=8.555(2)Å b=21.607(6)Å c=13.272(4)Å
α=90° β=98.413(4)° γ=90°
C22H20N6O2PtS4
C22H20N6O2PtS4
New Journal of Chemistry (2020) 44, 21 8878-8889
a=22.002(5)Å b=10.401(3)Å c=22.111(5)Å
α=90° β=90° γ=90°
2(C22H20N6O2S4),C2H6O
2(C22H20N6O2S4),C2H6O
New Journal of Chemistry (2020) 44, 21 8878-8889
a=8.4393(16)Å b=11.765(2)Å c=14.287(3)Å
α=86.938(3)° β=81.286(3)° γ=74.585(2)°
(3Z)-3-({[(ethylsulfanyl)methanethioyl]amino}imino)-2,3-dihydro-1<i>H</i>-indole-2-one
C11H11N3OS2
New Journal of Chemistry (2020) 44, 21 8878-8889
a=4.5172(2)Å b=13.5286(5)Å c=19.8833(7)Å
α=90° β=90° γ=90°
C22H20CoN6O2S4
C22H20CoN6O2S4
New Journal of Chemistry (2020) 44, 21 8878-8889
a=15.820(4)Å b=15.920(4)Å c=10.324(2)Å
α=90° β=108.978(3)° γ=90°
C14H7N2NiO8,2(H2O),H3O
C14H7N2NiO8,2(H2O),H3O
CrystEngComm (2014) 16, 24 5352
a=13.676(3)Å b=10.0513(19)Å c=13.785(3)Å
α=90° β=115.251(13)° γ=90°
C27H20Cr1N3O10
C27H20Cr1N3O10
CrystEngComm (2014) 16, 24 5352
a=13.4020(2)Å b=10.02710(10)Å c=19.8799(3)Å
α=90° β=108.994(2)° γ=90°
C14H6CrN2O8,C7H5NO4,C5H7N2,5(H2O)
C14H6CrN2O8,C7H5NO4,C5H7N2,5(H2O)
CrystEngComm (2014) 16, 24 5352
a=8.6936(8)Å b=11.1920(11)Å c=16.6210(16)Å
α=92.0870(10)° β=105.0460(10)° γ=95.7510(10)°
C12H12CuN4O6,H2O
C12H12CuN4O6,H2O
CrystEngComm (2014) 16, 27 6149
a=11.986(2)Å b=7.6602(14)Å c=15.750(3)Å
α=90° β=94.123(3)° γ=90°
C6H6CoN2,2(H2O)
C6H6CoN2,2(H2O)
CrystEngComm (2014) 16, 27 6149
a=12.5445(4)Å b=7.3874(3)Å c=11.8763(6)Å
α=90° β=111.118(1)° γ=90°
C14H20Cu2N2O15
C14H20Cu2N2O15
CrystEngComm (2014) 16, 27 6149
a=8.3425(5)Å b=27.1640(17)Å c=9.5946(6)Å
α=90.00° β=98.111(2)° γ=90.00°
C12H17N2O4S2V
C12H17N2O4S2V
RSC Advances (2018) 8, 73 41795
a=8.0281(17)Å b=10.127(2)Å c=11.104(2)Å
α=110.554(3)° β=110.250(3)° γ=94.785(3)°
C11H14MoN2O4S2
C11H14MoN2O4S2
RSC Advances (2018) 8, 73 41795
a=10.0788(8)Å b=9.8639(8)Å c=14.4725(11)Å
α=90° β=90.690(1)° γ=90°
C12H16Cl2N2O2S3Sn
C12H16Cl2N2O2S3Sn
RSC Advances (2018) 8, 73 41795
a=8.5293(4)Å b=9.3173(5)Å c=12.6067(6)Å
α=100.635(1)° β=108.831(1)° γ=94.334(1)°
C20H20N4O2S4Sn
C20H20N4O2S4Sn
RSC Advances (2018) 8, 73 41795
a=7.7957(7)Å b=24.197(2)Å c=12.3003(10)Å
α=90° β=101.157(1)° γ=90°
C20H20MnN4O2S4
C20H20MnN4O2S4
RSC Advances (2018) 8, 73 41795
a=7.7764(10)Å b=24.056(3)Å c=12.1308(15)Å
α=90° β=104.462(2)° γ=90°
C8N4OReS4,C16H36N
C8N4OReS4,C16H36N
Chem.Commun. (2015) 51, 5482
a=11.5743(8)Å b=11.7501(8)Å c=12.5007(8)Å
α=86.4890(10)° β=86.7430(10)° γ=60.9870(10)°
C72H99Cl4N36O29.5
C72H99Cl4N36O29.5
Chemical Communications (2005) 36 4542-4544
a=12.938(2)Å b=14.613(2)Å c=25.703(4)Å
α=88.608(2)° β=89.882(2)° γ=76.149(2)°
C8H14N8O7Pt2Th1,10(H2O)
C8H14N8O7Pt2Th1,10(H2O)
Chemical Communications (2010) 46, 27 4944-4946
a=13.2464(6)Å b=20.5599(10)Å c=22.4536(11)Å
α=90.00° β=90.00° γ=90.00°
4(C8N8O5Pt2U2),N2O6,2(O),8(O0.13),6(K)
4(C8N8O5Pt2U2),N2O6,2(O),8(O0.13),6(K)
Chemical Communications (2010) 46, 27 4944-4946
a=22.1073(2)Å b=22.1073(2)Å c=12.6202(2)Å
α=90.00° β=90.00° γ=90.00°
C12H22N12O12Pt3Th2,5(H2O)
C12H22N12O12Pt3Th2,5(H2O)
Chemical Communications (2010) 46, 27 4944-4946
a=16.4915(4)Å b=12.1941(4)Å c=19.5380(5)Å
α=90.00° β=114.016(4)° γ=90.00°
C23H21N2O
C23H21N2O
CrystEngComm (2012) 14, 5 1515
a=7.6366(7)Å b=15.5557(14)Å c=15.0141(14)Å
α=90.00° β=90.3950(10)° γ=90.00°
C23H21N2O2
C23H21N2O2
CrystEngComm (2012) 14, 5 1515
a=14.428(2)Å b=7.4072(12)Å c=33.289(5)Å
α=90.00° β=91.483(2)° γ=90.00°
C23H21N2O2
C23H21N2O2
CrystEngComm (2012) 14, 5 1515
a=9.9817(2)Å b=7.36870(10)Å c=25.0583(5)Å
α=90.00° β=94.737(1)° γ=90.00°
C23H21N2O
C23H21N2O
CrystEngComm (2012) 14, 5 1515
a=10.322(5)Å b=7.181(3)Å c=24.037(11)Å
α=90.00° β=98.018(6)° γ=90.00°
2(C23H21N2O2),C10F8,2(CH2Cl2)
2(C23H21N2O2),C10F8,2(CH2Cl2)
CrystEngComm (2013) 15, 5 831
a=13.8838(8)Å b=10.1039(6)Å c=18.7348(11)Å
α=90.00° β=107.125(1)° γ=90.00°
C41H88Cl2Cu4I4N14P4
C41H88Cl2Cu4I4N14P4
Dalton Transactions (2008) 25 3272-3274
a=10.2608(8)Å b=18.556(1)Å c=18.541(1)Å
α=68.787(1)° β=80.755(1)° γ=81.243(1)°
C56H90Cu4I4N14O4P4
C56H90Cu4I4N14O4P4
Dalton Transactions (2008) 25 3272-3274
a=22.928(1)Å b=14.8182(7)Å c=21.085(1)Å
α=90.00° β=90.00° γ=90.00°
Dichloro(mu-(1,3-di-tert-butyl-N,N,N',N-tetraethyl- (1,3,2,4)diazadiphosphetidine-2,4-diamine)digold(i)
C16H38Au2Cl2N4P2
Dalton Transactions (2009) 28 5478-5486
a=16.954(1)Å b=16.680(1)Å c=17.748(1)Å
α=90.00° β=90.00° γ=90.00°
Chloro(1,3-di-tert-butyl-2,4-bis(2-methoxyphenoxy)-(1,3,2,4)- diazadiphosphetidine)gold(i)
C22H32AuClN2O4P2
Dalton Transactions (2009) 28 5478-5486
a=8.7120(6)Å b=13.4408(9)Å c=22.399(2)Å
α=90.00° β=90.376(1)° γ=90.00°
Diiodo-mu-(1,3-di-tert-butyl-2,4-bis(2-methoxy- phenoxy)(1,3,2,4)diazadiphosphetidine)digold(i)
C22H32Au2I2N2O4P2
Dalton Transactions (2009) 28 5478-5486
a=9.0821(7)Å b=11.5920(9)Å c=15.340(1)Å
α=84.578(1)° β=85.850(1)° γ=67.053(1)°
(1,3-di-tert-butyl-2,4-bis(2-methoxyphenoxy)-2,4-bis (bromogold(i))(1,3,2,4)-diazadiphosphetidine) Acetonitrile Solvate
C23H33.50Au2Br2N2.50O4P2
Dalton Transactions (2009) 28 5478-5486
a=11.6834(6)Å b=12.5944(6)Å c=21.734(10)Å
α=102.171(1)° β=94.040(1)° γ=105.252(1)°
Cyclo-tetra(mu-1,3-di-tert-butyl-2,4-bis(o-methoxyphenoxy) (1,3,2,4)diazadiphpsphetidine-1kappaP:2kappaP')tetragold(i) perchlorate hydrate
C88H128Au4Cl4N8O34.5P8
Dalton Transactions (2009) 28 5478-5486
a=15.963(2)Å b=23.774(2)Å c=33.140(3)Å
α=90.00° β=107.852(1)° γ=90.00°
Dichlorobis(acetonitrile)(μ-1,4-Bis[bis(bis(o- methoxyphenoxy)phosphino)amino]benzene-1κ^2^P,P; 2κ^2^P",P"')dirhodium(I)
C66H66Cl2N4O16P4Rh2
Dalton Transactions (2009) 11 1984-1990
a=9.2409(5)Å b=11.0859(6)Å c=17.0064(9)Å
α=84.207(1)° β=77.819(1)° γ=88.350(1)°
Catena-Poly{dichloro(μ-1,4-bis(bis(bis(2- methoxyphenoxy)phospino)amino)benzene-1κ^2^ P,P:2κ^2^P",P"')(μ-pyrazine-1κN:2κN') dirhodium(I)}
C66H64Cl2N4O16P4Rh2
Dalton Transactions (2009) 11 1984-1990
a=16.9519(9)Å b=11.3413(6)Å c=18.325(1)Å
α=90.00° β=110.072(1)° γ=90.00°
C62H39CuINO6P2S3
C62H39CuINO6P2S3
Dalton Transactions (2008) 17 2285-2292
a=14.799(1)Å b=16.396(1)Å c=22.002(2)Å
α=90.00° β=104.064(1)° γ=90.00°
C70H44CuI2.33N2O6P2S3
C70H44CuI2.33N2O6P2S3
Dalton Transactions (2008) 17 2285-2292
a=38.803(3)Å b=13.801(1)Å c=17.579(1)Å
α=90.00° β=90.00° γ=90.00°
Catena-(bis(mu-trifluoromethanesulfonato-\1kO:\2kO)bis (mu- (1,3-di-tert-butyl-2,4-bis(o-methoxyphenoxy)-(1,3,2,4) diazadiphosphetidine-1kappaP:2kappaP')disilver(i))
C46H64Ag2F6N4O14P4S2
Dalton transactions (Cambridge, England : 2003) (2007) 27 2957-2962
a=14.127(1)Å b=19.570(2)Å c=21.228(2)Å
α=90.00° β=90.00° γ=90.00°
C23H32AgN3O4P2
C23H32AgN3O4P2
Dalton transactions (Cambridge, England : 2003) (2007) 27 2957-2962
a=16.482(1)Å b=16.069(1)Å c=22.312(2)Å
α=90.00° β=105.269(1)° γ=90.00°
Tetracarbonyl(bis(2-diphenylphosphinoxynaphthalen-1-yl) methane)molybdenum(0) dichloromethane solvate
C50H36Cl2MoO6P2
Dalton transactions (Cambridge, England : 2003) (2006) 10 1322-1330
a=10.7256(7)Å b=11.4602(8)Å c=17.609(1)Å
α=77.918(1)° β=83.014(1)° γ=88.284(1)°
Chloro(bis(2-diphenylphosphinoxynaphthalen-1-yl) methane)gold(I)
C46H34AuCl3O2P2
Dalton transactions (Cambridge, England : 2003) (2006) 10 1322-1330
a=12.337(1)Å b=12.453(1)Å c=12.806(1)Å
α=84.941(1)° β=88.464(1)° γ=78.992(1)°
Dichloro(bis(2-diphenylphosphinoxynaphthalen-1-yl) methane)digold(I)
C45H34Au2Cl2O2P2
Dalton transactions (Cambridge, England : 2003) (2006) 10 1322-1330
a=16.935(2)Å b=12.521(2)Å c=20.620(3)Å
α=90.00° β=98.936(2)° γ=90.00°
Η^3^-allyl(bis(2-diphenylphosphinoxynaphthalen-1-yl) methane)palladium(II) tetrafluoroborate bis(dichloro methane) solvate
C50H43BCl4F4O2P2Pd
Dalton transactions (Cambridge, England : 2003) (2006) 10 1322-1330
a=19.924(2)Å b=10.741(1)Å c=22.488(2)Å
α=90.00° β=108.071(1)° γ=90.00°
Dichloro(bis(2-diphenylphosphinoxynaphthalen-1-yl) methane)nickel(II) dichloromethane solvate
C46H36Cl4NiO2P2
Dalton transactions (Cambridge, England : 2003) (2006) 10 1322-1330
a=15.008(1)Å b=10.9488(9)Å c=26.287(2)Å
α=90.00° β=105.429(1)° γ=90.00°